UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 319

Sortiert nach

Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality

Supportive care in cancer, 2021-02, Vol.29 (2), p.1047-1053

2021

Link zum Volltext

Verfügbarkeit prüfen

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells

Journal of cancer research and therapeutics, 2020-12, Vol.16 (Supplement), p.S43-47

2020

Link zum Volltext

Verfügbarkeit prüfen

Chylous Acid that Develops After COVID-19 Infection in A Patient with Ovarian Cancer

Gazi tıp dergisi, 2021-10, Vol.32 (4), p.593-595

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Indian journal of cancer, 2021-10, Vol.58 (4), p.561-566

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

BMC cancer, 2023-10, Vol.23 (1), p.1-1045, Article 1045

2023

Link zum Volltext

Verfügbarkeit prüfen

Niraparib-induced pure red cell aplasia

Journal of oncology pharmacy practice, 2024-01, Vol.30 (1), p.210-214

2024

Link zum Volltext

Verfügbarkeit prüfen

Current status of biosimilars in Turkey: A survey among medical oncologists

Journal of oncology pharmacy practice, 2022-10, Vol.28 (7), p.1516-1523

2022

Link zum Volltext

Verfügbarkeit prüfen

Spinal paragangliomas: Surgical treatment and follow-up outcomes in eight cases

Medicine (Baltimore), 2018-09, Vol.97 (38), p.e12468-e12468

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

The oncologist (Dayton, Ohio), 2023-10, Vol.28 (10), p.875-884

2023

Link zum Volltext

Verfügbarkeit prüfen

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

The New England journal of medicine, 2014-10, Vol.371 (16), p.1555-1557

2014

Link zum Volltext

Verfügbarkeit prüfen

Re: Post-progression outcomes of NSCLC patients with PD-L1 expression ≥50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

European journal of cancer (1990), 2021-09, Vol.155, p.294-295

2021

Link zum Volltext

Verfügbarkeit prüfen

Combination therapies in non-clear-cell renal cell carcinoma

The lancet oncology, 2023-10, Vol.24 (10), p.e401-e401

2023

Link zum Volltext

Verfügbarkeit prüfen

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

The New England journal of medicine, 2023-08, Vol.389 (5), p.476

2023

Link zum Volltext

Verfügbarkeit prüfen

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Journal of clinical oncology, 2022-12, Vol.40 (34), p.4027-4027

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Journal of clinical oncology, 2022-11, Vol.40 (33), p.3898-3898

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of diabetes-related cerebellar changes in streptozotocin-induced diabetic rats

Turkish journal of medical sciences, 2016-01, Vol.46 (5), p.1579-1592

2016

Link zum Volltext

Verfügbarkeit prüfen

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Journal of clinical oncology, 2022-07, Vol.40 (19), p.JCO2200084-2178

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients

Nutrition and cancer, 2023, Vol.75 (1), p.368-375

2023

Link zum Volltext

Verfügbarkeit prüfen

Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma

Indian journal of pharmacology, 2014-01, Vol.46 (1), p.125-126

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade

JAMA oncology, 2023-04, Vol.9 (4), p.570

2023

Link zum Volltext

Verfügbarkeit prüfen

How molecularly similar are primary and metastatic tissues in renal cell carcinoma?

The lancet oncology, 2022-07, Vol.23 (7), p.e316-e316

2022

Link zum Volltext

Verfügbarkeit prüfen

Herpes zoster infection of the breast

The breast journal, 2020-11, Vol.26 (11), p.2267-2268

2020

Link zum Volltext

Verfügbarkeit prüfen

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Journal of clinical oncology, 2023-01, Vol.41 (2), p.416-417

2023

Link zum Volltext

Verfügbarkeit prüfen

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer

Supportive care in cancer, 2023-08, Vol.31 (8), p.500-500, Article 500

2023

Link zum Volltext

Verfügbarkeit prüfen

Do all aromatase inhibitors have similar efficacy and safety?

Future oncology (London, England), 2017-08, Vol.13 (19), p.1673-1676

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(277)

Publikationsform

Artikel
(312)
Berichte
(6)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells

Chylous Acid that Develops After COVID-19 Infection in A Patient with Ovarian Cancer

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

Niraparib-induced pure red cell aplasia

Current status of biosimilars in Turkey: A survey among medical oncologists

Spinal paragangliomas: Surgical treatment and follow-up outcomes in eight cases

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Re: Post-progression outcomes of NSCLC patients with PD-L1 expression ≥50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

Combination therapies in non-clear-cell renal cell carcinoma

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Analysis of diabetes-related cerebellar changes in streptozotocin-induced diabetic rats

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients

Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma

Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade

How molecularly similar are primary and metastatic tissues in renal cell carcinoma?

Herpes zoster infection of the breast

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer

Do all aromatase inhibitors have similar efficacy and safety?

Suchergebnisse filtern